Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

Clinical trial NCT06470451 · TERMINATED

Trial details

NCT number: NCT06470451
Sponsor: Soligenix
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

CTCL/ Mycosis Fungoides CTCL Mycosis Fungoides Cutaneous T Cell Lymphoma

Start date: 2025-01-07
Primary completion: 2026-05-22
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.